CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Acarbose treatment enhances levels of midregional-pro-atrial-natriuretic peptide: Evidences for gut-heart-axis?
DOI 10.1055/s-0030-1253959
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN Rudovich, A Ernst, MO Weickert, O Pivovarova, AM Arafat, NG Morgenthaler, A Bergmann, AFH Pfeiffer
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Acarbose unexpectedly reduced blood pressure and especially new cases of hypertension in the STOP-NIDDM study. Atrial natriuretic peptide (ANP) is a potent natriuretic and vasorelaxant hormone that is secreted mainly by cardiomyocytes and plays contributory roles in cardiovascular homeostasis. In the subjects with Metabolic Syndrome (MS) circulating level of N-terminal natriuretic peptides are decreased for un…
Zitieren
Zitierempfehlung
N Rudovich, A Ernst, MO Weickert, O Pivovarova, AM Arafat, NG Morgenthaler, A Bergmann, AFH Pfeiffer (2010) Acarbose treatment enhances levels of midregional-pro-atrial-natriuretic peptide: Evidences for gut-heart-axis?. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0030-1253959
Mit CareLit weiterarbeiten